ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 20 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,256,241 | -15.3% | 1,500,000 | -40.0% | 0.01% | +25.0% |
| Q4 2023 | $1,483,146 | +14.1% | 2,500,000 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $1,300,000 | -25.3% | 2,500,000 | -28.6% | 0.01% | -33.3% |
| Q2 2023 | $1,739,150 | +23.9% | 3,500,000 | 0.0% | 0.01% | +28.6% |
| Q1 2023 | $1,403,850 | -27.1% | 3,500,000 | 0.0% | 0.01% | -50.0% |
| Q4 2022 | $1,925,000 | -2.3% | 3,500,000 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $1,971,000 | +1.7% | 3,500,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $1,938,000 | +7.4% | 3,500,000 | 0.0% | 0.01% | +80.0% |
| Q1 2022 | $1,805,000 | -2.2% | 3,500,000 | 0.0% | 0.01% | +66.7% |
| Q4 2021 | $1,846,000 | – | 3,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 41,029,000 | $32,542,716 | 10.61% |
| Two Seas Capital LP | 17,275,000 | $10,041,094 | 2.45% |
| Whitefort Capital Management, LP | 4,900,000 | $2,848,125 | 1.82% |
| Saltoro Capital, LP | 1,000,000 | $593,258 | 1.58% |
| DCF Advisers, LLC | 2,950,000 | $1,722,063 | 0.94% |
| Context Capital Management, LLC | 17,851,000 | $10,590,249 | 0.71% |
| SILVERBACK ASSET MANAGEMENT LLC | 6,500,000 | $3,836,430 | 0.53% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,250,000 | $12,988,438 | 0.53% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 33,100,000 | $19,140,347 | 0.34% |
| WHITEBOX ADVISORS LLC | 16,850,000 | $9,743,651 | 0.27% |